-
Mashup Score: 7SABCS24 ONCOALERT | ONCOBITES - 2 hour(s) ago
In an interview, Dr. Agostinetto delves into the findings of Dr. Souza, who shares the results of his research explaining why larotrectinib is positioned as an effective and safe treatment option for patients with TRK fusion breast cancer. Dr. Cristiano de P á dua Souza MD, Jules Bordet Institute, Brussels,
Source: www.oncobites.tvCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 2Mirrors of Medicine - PinPoint cases - Prostate cancer - 4 hour(s) ago
Clinical cases about important clinical topics about Prostate cancer
Source: ppcp.mirrorsmed.orgCategories: General Medicine News, Oncologists1Tweet-
Clinical Case Challenges on Castrate Resistant Prostate Cancer by Mirrors of Medicine (Free & CME Accredited) Link to access👉 https://t.co/fRjiRCuEdK Join the Mirrors of Medicine PinPoint Case Platform, a case-based CME tool that helps apply the latest evidence to practice.… https://t.co/AjbvEWhADT https://t.co/gtVf9XmDXo
-
-
Mashup Score: 24APCCC Diagnostics 2025 - APCCC - 4 hour(s) ago
The diagnostic abilities for assessing prostate cancer patients have significantly evolved in the last years. Ranging from advanced imaging modalities for detection, new innovative liquid and tissue based biomarkers as well as the recent introduction of PSMA PET imaging have significantly advanced the field, challenging some of the old grounds of truth. The introduction of the Advanced Prostate Cancer Consensus Conference (APCCC) in 2015 represents a milestone of establishing clinical consensus in the
Source: apccc.orgCategories: General Medicine News, Oncologists1Tweet-
Dear Colleagues A warm invitation to JOIN US at #APCCCDiagnostics25 A HYBRID Meeting (In Person & Live) in Lugano Switzerland February 27-28, 2025 REGISTER: https://t.co/liXpdhy66c Enjoy Early Bird Registration, NOW OPEN ONLINE REGISTRATION FOR LMIC's FREE‼️ OncoAlert 🚨Will… https://t.co/UyKObpyq07 https://t.co/pPhDUcVQN5
-
-
Mashup Score: 5High5 Oncology TV: SABCS 2024 - 4 hour(s) ago
Für den erfolgreichen Abschluss der Fortbildungsmodule ist die korrekte (mind. 70%) Beantwortung der Lernerfolgskontrolle für das jeweilige Modul verpflichtend. Jetzt gleich den Fragebogen ausfüllen! Durch die Eingabe Ihrer individuellen einheitlichen Fortbildungsnummer (EFN) können Sie CME Fortbildungspunkte sammeln. Die bayrische Landesärztekammer erkennt dabei in jedem Fortbildungsmodul pro 45 min Videoeinheit 2 CME Punkte an. Maximal sind pro Fortbildungsmodul 4 CME Punkte möglich. Für den erfolgreiche
Source: high5oncology.tvCategories: General Medicine News, Oncologists1Tweet-
The FASCINATE Trial Report with Wolfgang Janni ( @high5md ) https://t.co/Zh3w52S9tk This study identified immune and tumor cell-related biomarkers that influence response to the anti-HER2 ADC SHR-A1811 in HER2+ breast cancer, with potential for enhancing efficacy through… https://t.co/IhGrIrWM2I https://t.co/XPhrfKCB7s
-
-
Mashup Score: 13SABCS 2024 Archives - VJOncology - 5 hour(s) ago
VJOncology are excited to attend the upcoming 47th San Antonio Breast Cancer Symposium (SABCS) 2024, bringing you the highly-anticipated trial data and insightful perspectives from leading experts in breast cancer! This international scientific symposium allows for important interactions and exchanges between basic scientists and clinicians devoted to improved diagnosis and treatment of breast cancer. Stay tuned for our coverage of the meeting, and catch up on the 2023 meeting below! VJOncology are
Source: www.vjoncology.comCategories: General Medicine News, Oncologists1Tweet-
Our Collaborators at @VJOncology are in San Antonio for #SABCS24 bringing you the highly-anticipated trial data and insightful perspectives from leading experts in #BreastCancer Find their Coverage here: https://t.co/yORESTUyvO Experts include @KalinskyKevin @matteolambe… https://t.co/7qtugUdaHG https://t.co/lruXvOrwc2
-
-
Mashup Score: 16High5 Oncology TV: SABCS 2024 - 5 hour(s) ago
Für den erfolgreichen Abschluss der Fortbildungsmodule ist die korrekte (mind. 70%) Beantwortung der Lernerfolgskontrolle für das jeweilige Modul verpflichtend. Jetzt gleich den Fragebogen ausfüllen! Durch die Eingabe Ihrer individuellen einheitlichen Fortbildungsnummer (EFN) können Sie CME Fortbildungspunkte sammeln. Die bayrische Landesärztekammer erkennt dabei in jedem Fortbildungsmodul pro 45 min Videoeinheit 2 CME Punkte an. Maximal sind pro Fortbildungsmodul 4 CME Punkte möglich. Für den erfolgreiche
Source: high5oncology.tvCategories: General Medicine News, Oncologists1Tweet-
Dear Colleagues at #SABCS24 Join our collaborators at @high5md STARTING TOMORROW for the latest #BreastCancer updates directly from San Antonio Visit them at: https://t.co/SnQEmcTqIa Featuring insights from some of the world’s leading international breast cancer experts… https://t.co/iviZqPMGtl https://t.co/vkvmdKyLu0
-
-
Mashup Score: 1The OncoAlert Newsletter is NOW OUT Click to Register - 6 hour(s) ago
The OncoAlert Newsletter is now out for June 23-29, 2023
Source: www.OncoAlert360.comCategories: General Medicine News, Onc News and JournalsTweet-
RT @BenWestphalen: Out today 💥 The new @OncoAlert 🚨 #newsletter - if you don’t want to miss out: register at https://t.co/AxMKHsMAQC 🌐
-
-
Mashup Score: 63The 5th Annual OncoAlert Colloquium - 6 hour(s) ago
The Year in Review in Oncology 2024 brought to you by some of the Worlds TOP experts!
Source: oncoalert.m-pages.comCategories: General Medicine News, Oncologists1Tweet-
The #OncoAlertColloquium 🚨Returns for its 5⃣th year The Year in Oncology 2024 with⚕️TOP Oncology Faculty and TOP Oncology Partners that will give this meeting a TRUE Interdisciplinary approach‼️ Registration is NOW OPEN LINK: https://t.co/IZgVZxwIYp See you soon! The Network… https://t.co/841qvpmNCz https://t.co/4Sz69h68aJ
-
-
Mashup Score: 63The 5th Annual OncoAlert Colloquium - 2 day(s) ago
The Year in Review in Oncology 2024 brought to you by some of the Worlds TOP experts!
Source: oncoalert.m-pages.comCategories: General Medicine News, Oncologists1Tweet-
The #OncoAlertColloquium 🚨Returns for its 5⃣th year The Year in Oncology 2024 with⚕️TOP Oncology Faculty and TOP Oncology Partners that will give this meeting a TRUE Interdisciplinary approach‼️ Registration is NOW OPEN LINK: https://t.co/IZgVZxwIYp See you soon! The Network… https://t.co/841qvpmNCz https://t.co/4Sz69h68aJ
-
-
Mashup Score: 19
Antagonistic monoclonal antibodies (mAbs) targeting inhibitory immune checkpoints have revolutionized the field of oncology. CTLA-4, PD-1, and LAG3 are three co-inhibitory receptors, which can be exp…
Source: onlinelibrary.wiley.comCategories: General Medicine News, Oncologists1Tweet-
RT @nataliagandur: 🔬 Checkpoint inhibitors and Fc functions: key findings in oncology immunotherapy 💡: https://t.co/1IpEIYUhIH @OncoAlert…
-
Join our collaborators at @OncobitesTv for an interview featuring @DrCrisPadua as he shares research on larotrectinib as an effective treatment for TRK fusion breast cancer. Link: https://t.co/k9RIIRx7nl Dr. @ElisaAgostinett Elisa Agostinetto from the Jules Bordet Institute in… https://t.co/YPDzOVivRA https://t.co/I59Ldib4g1